Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Membranoproliferative glomerulonephritis, albeit uncommon, is associated with considerable morbidity and mortality in children. Corticosteroids are the mainstay of therapy for severe disease, although data supporting their use are limited. We report our experience in treating two children with nephrotic-nephritic syndrome from idiopathic membranoproliferative glomerulonephritis. Both children experienced a suboptimal response to prolonged courses of steroids and were started on tacrolimus as a steroid-sparing agent. Rapid and complete remission was achieved in both children after initiation of tacrolimus. The purpose of our report is to increase awareness of health care professionals to the potential benefits of this agent in inducing remission in children with severe membranoproliferative glomerulonephritis.

Original languageEnglish (US)
Pages (from-to)1787-1791
Number of pages5
JournalPediatric Nephrology
Issue number10
StatePublished - Oct 2007


  • MPGN
  • Nephrotic syndrome
  • Pediatric
  • Remission

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus'. Together they form a unique fingerprint.

Cite this